|
CPEB4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6109336087311E-13 |
| Normal-vs-Stage2 |
9.93680004945929E-09 |
| Normal-vs-Stage3 |
8.59939897068784E-11 |
| Normal-vs-Stage4 |
2.74460000004861E-06 |
| Stage1-vs-Stage2 |
3.725900E-02 |
| Stage1-vs-Stage3 |
1.678040E-01 |
| Stage1-vs-Stage4 |
2.475000E-01 |
| Stage2-vs-Stage3 |
5.070400E-01 |
| Stage2-vs-Stage4 |
7.563400E-01 |
| Stage3-vs-Stage4 |
8.419200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
3.232700E-04 |
| Caucasian-vs-AfricanAmerican |
4.515400E-01 |
| Caucasian-vs-Asian |
5.719200E-01 |
| AfricanAmerican-vs-Asian |
7.454800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.96549451661576E-11 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
2.84883228118815E-13 |
| Normal-vs-Extreme_Obese |
1.82356999999245E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.241600E-01 |
| Normal_Weight-vs-Obese |
4.746000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.642600E-01 |
| Extreme_Weight-vs-Obese |
2.229400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.071800E-02 |
| Obese-vs-Extreme_Obese |
1.599750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.20103926803949E-12 |
| Normal-vs-Age(41-60Yrs) |
5.70432590052405E-13 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.04219999996769E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.678600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.389000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.078790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.753400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.035600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.849400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.73716596663098E-12 |
| Normal-VS-Type2 PRCC |
3.31229488281792E-11 |
| Normal-VS-KIRP CIMP |
2.64421817774974E-12 |
| Normal-VS-Unclassified PRCC |
2.9419799929542E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.32600000005245E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.303000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.742400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.401310E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.494200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.725800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.43929354282591E-15 |
| Normal-vs-N1 |
6.64119870208424E-11 |
| Normal-vs-N2 |
1.04360964314765E-13 |
| N0-vs-N1 |
6.584800E-01 |
| N0-vs-N2 |
9.786400E-04 |
| N1-vs-N2 |
2.050100E-02 |
|
|
